X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-08-17 | REZI | Resideo Technologies, Inc. | Mehta Amit Ashvin | SVP, Strategy, Business Ops | P - Purchase | $20.68 | +10,928 | 57,362 | +24% | +$225,999 | ||||||
| M | 2026-08-14 | NTHI | Neonc Technologies Holdings, Inc. | Chen Thomas C | CEO, 10% | P - Purchase | $3.86 | +36,259 | 4,660,135 | +1% | +$140,000 | |||||
| M | 2026-08-14 | VRCA | Verrica Pharmaceuticals Inc. | Rieger Jayson | CEO, Pres | P - Purchase | $5.03 | +25,000 | 208,298 | +14% | +$125,750 | |||||
2026-08-17 | AMRZ | Amrize Ltd | Poletti Samuel Jonas | Chief Strategy, M, A Officer | P - Purchase | $46.92 | +2,510 | 10,155 | +33% | +$117,769 | ||||||
2026-08-18 | ELAN | Elanco Animal Health Inc | O'Neill Shiv | GC, CORP SEC | P - Purchase | $23.58 | +3,998 | 87,832 | +5% | +$94,273 | ||||||
| D | 2026-08-18 | SRI | Stoneridge Inc | Humphrey Scott Randall | CFO, Treasurer | P - Purchase | $7.01 | +6,000 | 6,000 | New | +$42,060 | |||||
| M | 2026-08-17 | VRCA | Verrica Pharmaceuticals Inc. | Rosenberg Noah L. | CMO | P - Purchase | $4.91 | +6,230 | 8,587 | +264% | +$30,610 | |||||
2026-08-17 | VRCA | Verrica Pharmaceuticals Inc. | Zawitz David | COO | P - Purchase | $4.98 | +6,000 | 27,000 | +29% | +$29,880 | ||||||
2026-08-18 | VRCA | Verrica Pharmaceuticals Inc. | Kirby John J. | Interim CFO | P - Purchase | $4.93 | +5,000 | 23,962 | +26% | +$24,650 | ||||||
2026-08-14 | ACON | Aclarion, Inc. | Gould Gregory A | CFO | P - Purchase | $2.45 | +10,000 | 60,000 | +20% | +$24,500 | ||||||
2026-08-18 | TG | Tredegar Corp | Dasgupta Arijit | See Remarks | P - Purchase | $7.87 | +2,093 | 147,437 | +1% | +$16,472 | ||||||
2026-08-14 | TG | Tredegar Corp | Dasgupta Arijit | See Remarks | P - Purchase | $7.87 | +907 | 145,344 | +1% | +$7,138 | ||||||
| M | 2026-08-17 | MLCI | Mount Logan Capital Inc. | Satoren Brandon | CFO | P - Purchase | $3.08 | +2,000 | 19,814 | +11% | +$6,150 | |||||
2026-08-17 | RVSB | Riverview Bancorp Inc | Lam David | EVP, CFO | P - Purchase | $5.17 | +1,000 | 82,805 | +1% | +$5,170 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |